Thymalin vs Vesilute
Well Studied vs Moderate Research
compatible Different target systems; no known negative interactions.
Molecular Data
Thymalin Vesilute
Weight Variable (peptide complex) 262 Da
Half-life Not established (complex mixture); effects persist for weeks Not established
Chain — 2 amino acids
Type Polypeptide mixture Dipeptide bioregulator
Key Benefits
Thymalin
01 Potent immune system restoration and modulation
02 Significant geroprotective (anti-aging) effects
03 Reduced mortality rate in clinical studies (2.0-2.1 fold)
04 Normalized cardiovascular, endocrine, and nervous system function
05 Reduced acute respiratory disease incidence (2.0-2.4 fold)
06 Enhanced T-lymphocyte differentiation (CD4+, CD8+)
07 Antitumor effects in animal studies
08 Safe for elderly populations with no side effects
Vesilute
01 Supports bladder and urinary tract function
02 May improve prostate health in men
03 Regulates smooth muscle function
04 Enhances pelvic tissue blood flow
05 Supports cellular regeneration
06 Part of comprehensive Khavinson bioregulator protocols
07 Well-tolerated in research
08 Oral bioavailability as small dipeptide
Dosing Protocols
Thymalin
10mg per injection / Daily for 5-10 days, then break
Immune restoration 10 mg Daily
Standard cycle 10 mg Daily for 5-10 days
Maintenance 10 mg 1-2x yearly cycles
With Epithalamin 10 mg each Annual cycles
Vesilute
10-20 mg per day / Daily for 10-20 consecutive days (Khavinson bioregulator cycle)
Standard protocol 10-20 mg Daily for 10-20 days
Maintenance 20 mg 2-3 cycles yearly
Side Effects
Thymalin
Injection site reactions (mild)
Practically no side effects reported
Vesilute
Generally well-tolerated
Injection site reactions (mild, if injectable)
Minimal reported side effects
Contraindications
Autoimmune diseases (use with caution)
Organ transplant recipients (immunosuppression needed)
Pregnancy or breastfeeding
Known hypersensitivity
Known hypersensitivity to peptide components
Active urinary tract infection (treat first)
Pregnancy or breastfeeding
Prostate cancer (consult physician)
Research Evidence
Thymalin Vesilute
Status Well Studied Moderate Research
References 4 studies 3 studies
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.